logo
#

Latest news with #Ona

South West Sydney has scored a banging new spot serving ‘bloody good sandwiches'
South West Sydney has scored a banging new spot serving ‘bloody good sandwiches'

Time Out

time11-06-2025

  • Entertainment
  • Time Out

South West Sydney has scored a banging new spot serving ‘bloody good sandwiches'

Some people may say Sydney doesn't need another sandwich shop. We are not those people. So, say hello to San San – a funky new sandwich joint in Revesby, in Sydney's south west. Created by a sibling trio who says they 'couldn't find sandwiches in Sydney that hit the spot for us... so we made them ourselves', San San serves up loaded sandwiches featuring fluffy, freshly made focaccia, house-made sauces and quality ingredients. The succinct menu is made up of ten options, spanning deli meats, chicken schnitzel and vegan and vegetarian numbers. If it's your first time, a solid choice is the mortadella, which comes with fig jam, ricotta, hot honey, fresh rocket and potato crisps for crunch. We also like the sound of the OG schnitty, featuring golden chicken schnitzel paired with special San San sauce, butter lettuce, American cheese and pickled red onion. Or, for a flavour-packed veggie option, go for the eggplant with house-made baba ganoush (using a family recipe), marinated eggplant, roasted capsicum and a balsamic glaze. There's also a breakfast roll, chicken salad, focaccia pizza by the slice and chewy, gooey cookies. Plus, enjoy house-made lemonade and coffee using Ona beans. San San is open seven days a week – and you can dine in or take away.

REVEAL GENOMICS and Ona Therapeutics Join Forces to Advance Next-generation Cancer Treatment
REVEAL GENOMICS and Ona Therapeutics Join Forces to Advance Next-generation Cancer Treatment

Associated Press

time14-04-2025

  • Business
  • Associated Press

REVEAL GENOMICS and Ona Therapeutics Join Forces to Advance Next-generation Cancer Treatment

BARCELONA, Spain--(BUSINESS WIRE)--Apr 14, 2025-- REVEAL GENOMICS and Ona Therapeutics today announced a strategic collaboration aimed at accelerating the clinical development of ONA-255, a next-generation ADC designed to enhance the precision and efficacy of cancer treatment across multiple tumor types. This press release features multimedia. View the full release here: ONA-255 is positioned to be a first-in-class molecule against a novel ADC target present in multiple, prevalent solid tumor types. Ona has privileged insight of the target as a hallmark of molecular adaptation in advanced diseases and its unique function as a universal driver of resistance to various therapies. ONA-255 is an ADC tailor-made to match the design of the molecule to the extraordinary biology of the target to deliver exceptionally potent drug against recalcitrant tumors, especially resistant clones for deeper and more durable responses. At the heart of this collaboration is Dr. Aleix Prat, Co-Founder and Chief Scientific Officer of REVEAL GENOMICS. A globally recognized expert in precision oncology and drug development, Dr. Prat played a key role in identifying the ONA-255 drug target and generating, in collaboration with Ona Therapeutics and Dr. Roger Gomis, the critical preclinical data necessary for its clinical advancement. He also serves as the head of Ona Therapeutics' advisory board. As a leader in genomic innovation, REVEAL GENOMICS will conduct a comprehensive molecular analysis of tumor and blood samples from the ONA-255 phase 1-2 clinical trial as part of this strategic collaboration. Leveraging proprietary technologies and advanced computational algorithms, the company will decode key molecular and genomic biomarkers to reveal insights into tumor biology, the immune microenvironment, and response mechanisms to ONA-255. This pioneering work will help define patient populations, identify predictive biomarkers, and deepen the understanding of ONA-255's mechanism of action—accelerating its clinical development and opening new therapeutic avenues. To advance this partnership, Ona Therapeutics—working in collaboration with the U.S. subsidiary of REVEAL GENOMICS—has been awarded a grant from CDTI ( Centro para el Desarrollo Tecnológico y la Innovación ), a public entity under the Spanish Ministry of Science, Innovation, and Universities that promotes technological innovation and development. The grant is funded by the Plan de Recuperación, Transformación y Resiliencia – Funded by the European Union NextGenerationEU. Valerie Vanhooren, Co-Founder and CEO of Ona Therapeutics, added, " ADCs have transformed cancer treatment; however, the technology has been applied to a limited number of tumor targets. These limitations restrict the number of patients who can benefit from treatments and highlight the critical need to identify new broadly expressed tumor targets. Ona's tailor-designed ADCs have the potential to define new treatment paradigms and patient populations, resulting in a clear benefit for patients with cancer. This partnership with REVEAL GENOMICS combines Ona's ADC experience with cutting-edge diagnosticswith the goal to transform the treatment landscape for aggressive solid tumors.' Patricia Villagrasa, Co-Founder and CEO of REVEAL GENOMICS, stated, " Ona Therapeutics is at the forefront of developing next-generation cancer therapies. This collaboration marks a key milestone in combining advanced diagnostics with innovative treatments, reinforcing the strategic value of integrating biomarker science early in drug development. It also underscores REVEAL GENOMICS's leadership in driving biomarker strategy and our commitment to shaping new business models that bring precision oncology closer to patients.' Dr. Aleix Prat commented, " For further information visit: For further information visit: View source version on Further information: Adriana Herrera,[email protected] KEYWORD: EUROPE SPAIN UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: SCIENCE OTHER SCIENCE BIOTECHNOLOGY RESEARCH ONCOLOGY HEALTH CLINICAL TRIALS OTHER HEALTH SOURCE: REVEAL GENOMICS Copyright Business Wire 2025. PUB: 04/14/2025 08:05 AM/DISC: 04/14/2025 08:06 AM

Black Heritage Trail of NH to host Juneteenth event on Ona Judge
Black Heritage Trail of NH to host Juneteenth event on Ona Judge

Yahoo

time24-03-2025

  • Entertainment
  • Yahoo

Black Heritage Trail of NH to host Juneteenth event on Ona Judge

PORTSMOUTH — The Black Heritage Trail of New Hampshire will host a Juneteenth event titled "Never Caught: The Defiant Journey of Ona Marie Judge Staines." The program will take place on Thursday, June 12, at 5:30 p.m. at the Currier Museum of Art in Manchester, and will shed light on the remarkable life of Ona Judge, a woman born into slavery at George Washington's Mount Vernon estate who courageously escaped to freedom in Portsmouth, New Hampshire. The event features a dramatic reading of Ona Judge's 1845 interview, originally published in The Granite Freeman (Concord, N.H.), performed by acclaimed New Hampshire actress Sandi Clarke Kaddy. Following the reading, Dr. Erica Armstrong Dunbar, author of the Pulitzer Prize finalist "Never Caught: The Washingtons' Relentless Pursuit of Their Runaway Slave, Ona Judge," will discuss Judge's story and its lasting significance in the American struggle for freedom and justice. 'Ona's courageous act of self-liberation speaks to the larger American story of enslavement, the relentless quest for freedom, and the systemic forces that sought to maintain racial oppression,' said JerriAnne Boggis, executive director of the Black Heritage Trail of NH. 'We are looking forward to this event and offering deeper insight into Ona's story and its lasting significance in American history.' Presented in partnership with the Currier Museum of Art, this program is part of the Black Heritage Trail's mission to share the untold stories of African American history in the Granite State. Admission is free, but space is limited. For reservations, visit or call 603-570-8469. This article originally appeared on Portsmouth Herald: Black Heritage Trail of NH to host Juneteenth event on Ona Judge

Dog rescued from storm drain in Thompson's Station
Dog rescued from storm drain in Thompson's Station

Yahoo

time10-03-2025

  • Climate
  • Yahoo

Dog rescued from storm drain in Thompson's Station

WILLIAMSON COUNTY, Tenn. (WKRN) — Animal control officers with the Williamson County Animal Center responded to an 'urgent' rescue mission after a dog became trapped inside a Thompson's Station storm drain. Agencies work together to rescue horse from hole on Culleoka Highway The dog, named Ona, had become trapped 30 feet inside a storm drain Monday, according to a Facebook post from the Williamson County Animal Center. When animal control officers arrived, they heard Ona barking and scratching deep within the storm drain. Nearby construction workers and Ona's owner had tried to help, but they weren't able to reach her. An animal control officer crawled into the storm drain and — after some maneuvering, was able to safely pull Ona to safety. ADM issues recall for cattle feed sold in six states, including Tennessee After about three hours of being stuck in the drain, Ona was reunited with her owner. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store